Drug Development and Guideline for Safety Pharmacology Studies |
최기환
(식품의약품안전청 국립독성연구원 약리부)
박인숙 (식품의약품안전청 국립독성연구원 약리부) 임화경 (식품의약품안전청 국립독성연구원 약리부) 오우용 (식품의약품안전청 국립독성연구원 약리부) 왕소영 (식품의약품안전청 국립독성연구원 약리부) 김소희 (식품의약품안전청 국립독성연구원 약리) 김주일 (식품의약품안전청 국립독성연구원 약리부) 김동섭 (식품의약품안전청 국립독성연구원 약리부) |
1 |
Safety pharmacology requirements for the development of human cardiac/cardiovascular pharmaceuticals
/
DOI ScienceOn |
2 |
Japanese Ministry of Health and Welfare
/
|
3 |
An assessment of two gastric transport models currently used in safety pharmacology testing
/
DOI ScienceOn |
4 |
/
|
5 |
Safety pharmacology - a critical perspective
/
DOI ScienceOn |
6 |
Safety pharmacology studies for human pharmaceuticals
/
|
7 |
/
|
8 |
Preclinical safety evaluation of biotecnology-derived pharmaceuticals
/
|
9 |
/
|
10 |
Timing of non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals
/
|